PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer

ConclusionOur study suggests that PRMT5 may play an important role in the doxorubicin resistance of breast cancer.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research